Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Arnon NaglerMyriam LabopinYener KocEmanuele AngelucciJohanna TischerMutlu AratPietro PioltelliPaolo BernasconiPatrizia ChiusoloJ L Diez-MartinJamie SanzFabio CiceriZinaida PericSebastian GiebelJonathan CanaaniMohamad MohtyPublished in: Cancer (2021)
The outcome of adult patients with ALL who receive posttransplant cyclophosphamide has improved over time, with an impressive 2-year OS of 75% and, most recently, an NRM rate of only 17%.